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1. Introduction 
Nowadays, treatments of dyslipidemia go beyond lowering 
of blood lipid levels.  Activation of the immune system by various 
cytokines, free radicals and pro-inflammatory substances which 
contribute greatly to the regression of atherosclerosis has been 
explored [1].  The in vitro anti-oxidative property of fenofibrate, a 
drug used for the management of high triglyceride levels, has been 
demonstrated[2].  A certain class of hypolipidemic drugs known as 
statin inhibits hydroxymethylglutaryl CoA reductase inhibitors, the 
rate-limiting enzyme for the synthesis of cholesterol in the liver.  
Rosuvastatin has been shown to prevent oxidative stress in 
humans[3].  Atorvastatin inhibits oxidative pathways upregulated in 
atheroma [4].  Fluvastatin and simvastatin scavenge superoxide 
dismutase and inhibit low-density lipoprotein (LDL) oxidation [5].  
Currently, no studies on the in vitro anti-oxidative properties of the 
statins have been conducted.  This study seeks to determine and 
compare in terms of potencies the in vitro anti-oxidative properties of 
5 statins that are currently used for the management of dylipidemia.   
 
2. Materials and Methods 
2.1. Chemicals and Solvents 
 All solvents used were of reagent grades and purchased 
from Dakila Trading, Inc.  Samples of simvastatin, atorvastatin, 
rosuvastatin, fluvastatin and pravastatin were given as gifts from 
Deackchem, Inc.  Stock solutions of each drug in methanol were 
prepared and diluted accordingly with the solvent to prepare test 
samples with concenration ranges from 0 – 0.5 mg/mL.   
 
2.2. Inhibition of 2,2-Diphyenyl-1-Picrylhydrazyl (DPPH) 
 Exactly 0.3 ml of each test sample (n = 5 trials per statin 
concentration) and 0.3 mL of methanol (i.e., control) was added to 2 
mL portions of 1 mM DPPH (Sigma-Aldrich) in methanol in a series of 
test tubes.  The mixtures were kept at room temperature for 30 
minutes and then read for absorbance at 517 nm.   The % inhibition 
(% I) of DPPH free radical was calculated, thus:  % I = Ao – A/Ao, 
where Ao is absorbance of methanol solution while Ao is absorbance 
of the test sample after 30 minutes [6]. 
 
2.3. Inhibition of Lipid Peroxidation in Liver Homogenates 
 Livers of newly-slaughtered pigs were purchased from a 
local market.  Livers were washed with ice-cold 0.9% NaCl.  Liver 
homogenate was prepared using a blender in a ratio of 1 gram of wet 
tissue to 9 mL of 1.15% KCl.  To 0.1 mL portions of liver homogenate 
were added 0.1 mL of 0.5 mg/mL statin sample solution (n = 5 trials) 
or 0.1 mL methanol (i.e., blank control), 0.2 mL of 8.1% SDS, 1.5 mL of 
20% acetic acid solution adjusted to pH 3.5 with NaOH, and 1.5 mL of 
0.8% aqueous solution of TBA.  The mixture was made up to 4.0 mL 
with distilled water, and then heated at 950C for 60 minutes in a 
water bath.  After cooling with tap water, 1.0 mL of distilled water 
and 5.0 mL of the mixture of n-butanol and pyridine (1:15, v/v) were 
added.  After centrifugation at 4000 rpm for 10 minutes, the upper 
organic layer was measured for absorbance at 532 nm.  1,1,3,3-
tetramethoxypropane (TMP) was used as an external standard and 
the level of lipid peroxides was expressed as nmol of 
malondialdehyde (MDA) [7].    
 
3. Results 
 The ability of statins to scavenge or inhibit free radical 
formation by DPPH at 517 nm was explored to assess and compare in 
vitro anti-oxidative effects.  Figure 1 shows that among the 5 drugs 
tested, atorvastatin gave the lowest median inhibitory concentration 
(IC50).  Inhibition was concentration dependent (pearson r > 0.9) in 
all the test samples, with atorvastatin giving the highest linearity and 
slope (b).  The weak inhibitory effects of pravastatin and fluvastatin 
even at the maximum concentration of 0.5 mg/mL suggest weak in 
vitro free radical scavenging properties.   
 The second in vitro assay used in this study is the ability of 
statins to inhibit the formation of free radicals from polyunsaturated 
fatty acids in liver homogenates.  The end-product of this reaction is 
the formation of MDA which conjugates with TBA to form a reduced 
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colored complex known as thiobarbituric acid reactive species 
(TBARS).  Table 1 agrees with the findings in Figure 1 as both 
atorvastatin and simvastatin gave the highest % inhibition and gave 
the lowest formation of MDA.    
   
  Figure I: Comparative In Vitro Inhibition of DPPH Free Radical 
Formation Among Statins 
      
 
*p < 0.001 vs. the rest of the statins and corresponding % inhibition 
at 0.02 - 0.20 concentrations; ** p < 0.01 vs rosuvastatin, pravastatin 
and fluvastatin; n = 5/concentration/statin 
 
**p < 0.001 vs simvastatin, rosuvastatin, pravastatin and Fluvastatin; 
** p < 0.01 vs rosuvastatin, pravastatin and fluvastatin; n = 
5/concentration/statin 
 
Table 1: Comparative % Inhibition of TBARS and MDA 
Formation among Statins 
 
Statin 
% Inhibition of TBARS 
Formation 
MDA Formation in 
nM/mg 
Atorvastatin 91.4 ± 3.1* 0.32 ± 0.03* 
Simvastatin 89.2 ± 4.3* 0.27 ± 0.02* 
Rosuvastatin 77.5 ± 2.8 0.51 ± 0.05 
Pravastatin 28.4 ± 4.5 0.83 ± 0.11 
Fluvastatin 19.7 ± 4.0 0.92 ± 0.09 
   
  *p < 0.01 vs rosuvastatin, pravastatin and fluvastatin; n = 5 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4. Discussions 
 The role of oxidation in accelerating atherosclerosis can be 
coursed through the formation of free radicals which interact with 
low-density lipoproteins (LDL) to form foam cells in the coronary 
arteries.  The density of foam cell formation corresponds to the 
density of plaque formation during atheroslerosis.  This study shows 
that 3 statins, namely atorvastatin, simvastatin and rosuvastatin 
exhibit strong in vitro anti-oxidative properties, pleiotropic effects 
which may aid in reducing the harmful effects of free radical 
formation in addition to their LDL-lowering effects.  Unlike 
atorvastatin, rosuvastatin and simvastatin, both pravastatin and 
fluvastatin do not contain proton donors in their chemical structures 
(carboxyl hydrogen and amino hydrogen) which are needed to 
reduce MDA and sequester DPPH free radical formation.  Based on 
the findings from this study, it is recommended that in vivo anti-
oxidative enzymatic assays, using liver homogenates, be conducted 
for atorvastatin, simvastatin and rosuvastatin to fully determine the 
mechanisms by which their anti-oxidative properties are conveyed.   
 
5. Conclusions 
 This study was able to demonstrate the high in vitro anti-
oxidative properties of atorvastatin and simvastatn in terms of their 
free radical scavenging effects.  Simvastatin showed moderate anti-
oxidative properties.  On the other hand, pravastatin and fluvastatin 
gave weak inhibitory effects to in vitro free radical formation. 
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